Selected research
Industry Research
Non-Animal Softgel Capsules Industry Research Report 2026
Market perspective
The global Non-Animal Softgel Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Non-Animal Softgel Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Non-Animal Softgel Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Non-Animal Softgel Capsules include Sirio, Erkang, Baihe, Aland, Sunsho Pharmaceutical, Robinson Pharma, Procaps Laboratorios, Fuji Capsule and EuroCaps, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Non-Animal Softgel Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-Animal Softgel Capsules Market by Company
Sirio
Erkang
Baihe
Aland
Sunsho Pharmaceutical
Robinson Pharma
Procaps Laboratorios
Fuji Capsule
EuroCaps
Catalent
Captek
Bahrain Pharma
Aenova
Non-Animal Softgel Capsules Segment by Type
Starch Softgel
Gellan Gum Softgel
Carrageenan Softgel
Non-Animal Softgel Capsules Segment by Application
Health Supplements
Pharmaceutical
Others
Non-Animal Softgel Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Animal Softgel Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Animal Softgel Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Animal Softgel Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-Animal Softgel Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-Animal Softgel Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Starch Softgel
- Gellan Gum Softgel
- Carrageenan Softgel
Applications
- Health Supplements
- Pharmaceutical
- Others
Companies covered
- Sirio
- Erkang
- Baihe
- Aland
- Sunsho Pharmaceutical
- Robinson Pharma
- Procaps Laboratorios
- Fuji Capsule
- EuroCaps
- Catalent
- Captek
- Bahrain Pharma
- Aenova
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Non-Animal Softgel Capsules Market Size (2021-2032)
- 2.2.2 Global Non-Animal Softgel Capsules Sales (2021-2032)
- 2.2.3 Global Non-Animal Softgel Capsules Market Average Price (2021-2032)
- 2.3 Non-Animal Softgel Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Starch Softgel
- 2.3.3 Gellan Gum Softgel
- 2.3.4 Carrageenan Softgel
- 2.4 Non-Animal Softgel Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Health Supplements
- 2.4.3 Pharmaceutical
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Non-Animal Softgel Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Non-Animal Softgel Capsules Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Non-Animal Softgel Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Non-Animal Softgel Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Non-Animal Softgel Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Non-Animal Softgel Capsules, Product Type & Application
- 3.8 Global Manufacturers of Non-Animal Softgel Capsules, Established Date
- 3.9 Global Non-Animal Softgel Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sirio
- 4.1.1 Sirio Company Information
- 4.1.2 Sirio Business Overview
- 4.1.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sirio Non-Animal Softgel Capsules Product Portfolio
- 4.1.5 Sirio Recent Developments
- 4.2 Erkang
- 4.2.1 Erkang Company Information
- 4.2.2 Erkang Business Overview
- 4.2.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Erkang Non-Animal Softgel Capsules Product Portfolio
- 4.2.5 Erkang Recent Developments
- 4.3 Baihe
- 4.3.1 Baihe Company Information
- 4.3.2 Baihe Business Overview
- 4.3.3 Baihe Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baihe Non-Animal Softgel Capsules Product Portfolio
- 4.3.5 Baihe Recent Developments
- 4.4 Aland
- 4.4.1 Aland Company Information
- 4.4.2 Aland Business Overview
- 4.4.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Aland Non-Animal Softgel Capsules Product Portfolio
- 4.4.5 Aland Recent Developments
- 4.5 Sunsho Pharmaceutical
- 4.5.1 Sunsho Pharmaceutical Company Information
- 4.5.2 Sunsho Pharmaceutical Business Overview
- 4.5.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
- 4.5.5 Sunsho Pharmaceutical Recent Developments
- 4.6 Robinson Pharma
- 4.6.1 Robinson Pharma Company Information
- 4.6.2 Robinson Pharma Business Overview
- 4.6.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
- 4.6.5 Robinson Pharma Recent Developments
- 4.7 Procaps Laboratorios
- 4.7.1 Procaps Laboratorios Company Information
- 4.7.2 Procaps Laboratorios Business Overview
- 4.7.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
- 4.7.5 Procaps Laboratorios Recent Developments
- 4.8 Fuji Capsule
- 4.8.1 Fuji Capsule Company Information
- 4.8.2 Fuji Capsule Business Overview
- 4.8.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
- 4.8.5 Fuji Capsule Recent Developments
- 4.9 EuroCaps
- 4.9.1 EuroCaps Company Information
- 4.9.2 EuroCaps Business Overview
- 4.9.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
- 4.9.5 EuroCaps Recent Developments
- 4.10 Catalent
- 4.10.1 Catalent Company Information
- 4.10.2 Catalent Business Overview
- 4.10.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Catalent Non-Animal Softgel Capsules Product Portfolio
- 4.10.5 Catalent Recent Developments
- 4.11 Captek
- 4.11.1 Captek Company Information
- 4.11.2 Captek Business Overview
- 4.11.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Captek Non-Animal Softgel Capsules Product Portfolio
- 4.11.5 Captek Recent Developments
- 4.12 Bahrain Pharma
- 4.12.1 Bahrain Pharma Company Information
- 4.12.2 Bahrain Pharma Business Overview
- 4.12.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
- 4.12.5 Bahrain Pharma Recent Developments
- 4.13 Aenova
- 4.13.1 Aenova Company Information
- 4.13.2 Aenova Business Overview
- 4.13.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Aenova Non-Animal Softgel Capsules Product Portfolio
- 4.13.5 Aenova Recent Developments
5 Global Non-Animal Softgel Capsules Market Scenario by Region
- 5.1 Global Non-Animal Softgel Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Non-Animal Softgel Capsules Sales by Region: 2021-2032
- 5.2.1 Global Non-Animal Softgel Capsules Sales by Region: 2021-2026
- 5.2.2 Global Non-Animal Softgel Capsules Sales by Region: 2027-2032
- 5.3 Global Non-Animal Softgel Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Non-Animal Softgel Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Non-Animal Softgel Capsules Revenue by Region: 2027-2032
- 5.4 North America Non-Animal Softgel Capsules Market Facts & Figures by Country
- 5.4.1 North America Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Non-Animal Softgel Capsules Sales by Country (2021-2032)
- 5.4.3 North America Non-Animal Softgel Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Non-Animal Softgel Capsules Market Facts & Figures by Country
- 5.5.1 Europe Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Non-Animal Softgel Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Non-Animal Softgel Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Non-Animal Softgel Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Non-Animal Softgel Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Non-Animal Softgel Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Non-Animal Softgel Capsules Market Facts & Figures by Country
- 5.7.1 South America Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Non-Animal Softgel Capsules Sales by Country (2021-2032)
- 5.7.3 South America Non-Animal Softgel Capsules Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Non-Animal Softgel Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Non-Animal Softgel Capsules Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Non-Animal Softgel Capsules Sales by Type (2021-2032)
- 6.1.1 Global Non-Animal Softgel Capsules Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Non-Animal Softgel Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Non-Animal Softgel Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Non-Animal Softgel Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Non-Animal Softgel Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Non-Animal Softgel Capsules Sales by Application (2021-2032)
- 7.1.1 Global Non-Animal Softgel Capsules Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Non-Animal Softgel Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Non-Animal Softgel Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Non-Animal Softgel Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Non-Animal Softgel Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Non-Animal Softgel Capsules Value Chain Analysis
- 8.1.1 Non-Animal Softgel Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Non-Animal Softgel Capsules Production Mode & Process
- 8.2 Non-Animal Softgel Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Non-Animal Softgel Capsules Distributors
- 8.2.3 Non-Animal Softgel Capsules Customers
9 Global Non-Animal Softgel Capsules Analyzing Market Dynamics
- 9.1 Non-Animal Softgel Capsules Industry Trends
- 9.2 Non-Animal Softgel Capsules Industry Drivers
- 9.3 Non-Animal Softgel Capsules Industry Opportunities and Challenges
- 9.4 Non-Animal Softgel Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst